Karlberg Tobias, Collins Ruairi, van den Berg Susanne, Flores Alex, Hammarström Martin, Högbom Martin, Holmberg Schiavone Lovisa, Uppenberg Jonas
Structural Genomics Consortium, Karolinska Institutet, MBB/SGC, 171 77 Stockholm, Sweden.
Acta Crystallogr D Biol Crystallogr. 2008 Mar;64(Pt 3):279-86. doi: 10.1107/S0907444907067455. Epub 2008 Feb 20.
Argininosuccinate synthetase catalyzes the transformation of citrulline and aspartate into argininosuccinate and pyrophosphate using the hydrolysis of ATP to AMP and pyrophosphate. This enzymatic process constitutes the rate-limiting step in both the urea and arginine-citrulline cycles. Previous studies have investigated the crystal structures of argininosuccinate synthetase from bacterial species. In this work, the first crystal structure of human argininosuccinate synthetase in complex with the substrates citrulline and aspartate is presented. The human enzyme is compared with structures of argininosuccinate synthetase from bacteria. In addition, the structure also provides new insights into the function of the numerous clinical mutations identified in patients with type I citrullinaemia (also known as classic citrullinaemia).
精氨琥珀酸合成酶利用ATP水解生成AMP和焦磷酸,催化瓜氨酸和天冬氨酸转化为精氨琥珀酸和焦磷酸。这一酶促过程是尿素循环和精氨酸 - 瓜氨酸循环中的限速步骤。此前的研究已对来自细菌物种的精氨琥珀酸合成酶的晶体结构进行了探究。在这项工作中,首次展示了与底物瓜氨酸和天冬氨酸结合的人精氨琥珀酸合成酶的晶体结构。将人源酶与来自细菌的精氨琥珀酸合成酶的结构进行了比较。此外,该结构还为I型瓜氨酸血症(也称为经典瓜氨酸血症)患者中鉴定出的众多临床突变的功能提供了新的见解。